Oyster Point Pharma Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease
Multicenter, Randomized ONSET-2 Study Will Evaluate OC-01 as Novel Option for Common Eye Condition PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc.,…